Publications
5803 Results
- Journal / Conference
- Blood 122:3924, ASH annual meeting, poster presentation;
- Year
- 2013
- Research Committee(s)
- Leukemia
- Study Number(s)
- E1905
Azacitidine with our without entinostat for the treatment of therapy related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup study
- Journal / Conference
- Journal of Comparative Effectiveness Research 2(3):325-334
- Year
- 2013
- Research Committee(s)
- Breast
- PMID
- PMID24236631
- PMC
- PMC4018420
- Study Number(s)
- S1007
Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysis
- Journal / Conference
- Blood 122:4277; American Society of Hematology annual meeting (Dec 7-10, 2013, New Orleans, LA), poster;
- Year
- 2013
- Research Committee(s)
- Lymphoma
- Study Number(s)
- E2496
Evaluation of a novel 3 factor prognostic score (PS-3) for patients with advanced Hodgkin lymphoma (HL) treated on US Intergroup E2496
- Journal / Conference
- Seminars in Oncology 40(5):634-651
- Year
- 2013
- Research Committee(s)
- Myeloma
- PMID
- PMID24135408
- PMC
- PMC3819933
Novel agents for multiple myeloma to overcome resistance in phase III clinical trials
- Journal / Conference
- Journal of the American Medical Association 310(14):1455-1461
- Year
- 2013
- Research Committee(s)
- Breast
- PMID
- PMID24101169
- PMC
- PMC4075763
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial
- Journal / Conference
- International Journal of Radiation Oncology, Biology, Physics 87(4):638-645
- Year
- 2013
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID24035327
- PMC
- PMC3938865
- Study Number(s)
- R9811
Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial
- Journal / Conference
- Annals of Surgical Oncology 20(8):2787-2795
- Year
- 2013
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID23435609
- PMC
- PMC5600517
- Study Number(s)
- CTSU/A021101
Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design
- Journal / Conference
- New England Journal of Medicine 369(20):1968
- Year
- 2013
- Research Committee(s)
- Cancer Control
- PMID
- PMID24224632
- PMC
- PMC4927191
- Study Number(s)
- SWOG-9217
Survival in the prostate cancer prevention trial
- Journal / Conference
- Journal of Thoracic Oncology 8(suppl. 2): abstr. MO13.01; the 15th World Conference on Lung Cancer, October 2013, Sydney, Australia
- Year
- 2013
- Research Committee(s)
- Lung
- Study Number(s)
- S0327, S0435, S0802
Disease control rate at 8 weeks predicts subsequent survival in platinum-treated extensive stage small cell lung cancer (ES-SCLC): a patients level analysis of SWOG trials
- Journal / Conference
- Breast 22(5):606-615
- Year
- 2013
- Research Committee(s)
- Cancer Survivorship
- PMID
- PMID24007941
- PMC
- (reviews not within scope of Public Access Policy)